A Randomised, Double-Blind, Placebo Controlled, Crossover Study to Assess the Effect of ZD4522 on the Incorporation of Trideuterated Leucine into Lipid Subfractions and Apolipoproteins in Subjects with Mild to Moderate Hyperlipidaemia.
Study identifier:4522IL/0045
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Study Complete
Official Title
A Randomised, Double-Blind, Placebo Controlled, Crossover Study to Assess the Effect of ZD4522 on the Incorporation of Trideuterated Leucine into Lipid Subfractions and Apolipoproteins in Subjects with Mild to Moderate Hyperlipidaemia.
Medical condition
hypercholesterolaemia
Phase
Phase 3
Healthy volunteers
-
Study drug
-
Sex
-
Actual Enrollment
-
Study type
Interventional
Age
-
Date
Study Start Date: 01 Mar 2000
Primary Completion Date: -
Study Completion Date: -
Study design
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verification:
-
Sponsors
AstraZeneca
Collaborators
-
Inclusion and exclusion criteria
Loading...
No locations available
| Arms | Assigned Interventions |
|---|
